\nO nou\u0103 abordare \u00een tratamentul diabetului de tip 2 combin\u0103 medicamentul semaglutid cu o procedur\u0103 endoscopic\u0103 inovatoare, oferind rezultate promi\u0163\u0103toare. Studiul arat\u0103 c\u0103 metoda ar putea elimina necesitatea injec\u0163iilor cu insulin\u0103 pentru mul\u0163i pacien\u0163i.<\/p>\n
\nStudiul, prezentat la S\u0103pt\u0103m\u00e2na United European Gastroenterology, a implicat 14 pacien\u0163i cu diabet de tip 2, cu v\u00e2rste \u00eentre 28 \u015fi 75 de ani. Ace\u015ftia au fost supu\u015fi unei proceduri numite ReCet (Re-Cellularisation via Electroporation Therapy), urmat\u0103 de administrarea de semaglutid, substan\u0163a activ\u0103 din medicamentul Ozempic.<\/p>\n
\nRezultatele au fost impresionante, conform adnkronos.<\/p>\n
\n\u201eLa 6 \u015fi 12 luni de urm\u0103rire, 86% dintre participan\u0163i (12 din 14) nu au mai avut nevoie de insulinoterapie”, raporteaz\u0103 autorii studiului.<\/p>\n
\nBeneficiile s-au men\u0163inut timp de 24 de luni, iar pacien\u0163ii au p\u0103strat un control glicemic bun, cu niveluri ale hemoglobinei glicate sub 7,5%.<\/p>\n
\nSemaglutida, cunoscut\u0103 pentru efectele sale de sl\u0103bire, a fost bine tolerat\u0103 de 93% dintre participan\u0163i. Un singur pacient nu a putut cre\u015fte doza pentru c\u0103 \u00eei era grea\u0163\u0103.<\/p>\n
\nAbordarea ar putea reprezenta o schimbare semnificativ\u0103 \u00een tratamentul diabetului de tip 2, o boal\u0103 care afecteaz\u0103 422 de milioane de persoane la nivel global. Eliminarea necesit\u0103\u0163ii injec\u0163iilor cu insulin\u0103 ar putea \u00eembun\u0103t\u0103\u0163i semnificativ calitatea vie\u0163ii pacien\u0163ilor \u015fi ar putea simplifica gestionarea bolii.<\/p>\n
\nCercet\u0103torii descriu studiul ca fiind \u201erevolu\u0163ionar”, de\u015fi sunt necesare investiga\u0163ii suplimentare pe un num\u0103r mai mare de pacien\u0163i pentru a confirma aceste rezultate promi\u0163\u0103toare.<\/p>\n","protected":false},"excerpt":{"rendered":"
O nou\u0103 abordare \u00een tratamentul diabetului de tip 2 combin\u0103 medicamentul semaglutid cu o procedur\u0103 endoscopic\u0103 inovatoare, oferind rezultate promi\u0163\u0103toare. Studiul arat\u0103 c\u0103 metoda ar putea elimina necesitatea injec\u0163iilor cu insulin\u0103 pentru mul\u0163i pacien\u0163i. Studiul, prezentat la S\u0103pt\u0103m\u00e2na United European Gastroenterology, a implicat 14 pacien\u0163i cu diabet de tip 2, cu v\u00e2rste \u00eentre 28 \u015fi […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[15493,9258],"class_list":["post-230927","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-diabet","tag-insulina"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/230927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=230927"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/230927\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=230927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=230927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=230927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}